
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Mogamulizumab
Therapeutic Area : Oncology
Study Phase : Phase I
Recipient : Moffitt Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
Details : Mogamulizumab is a Antibody drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Mycosis Fungoides.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Inapplicable
January 31, 2024
Lead Product(s) : Mogamulizumab
Therapeutic Area : Oncology
Highest Development Status : Phase I
Recipient : Moffitt Cancer Center
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : HMO
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
Details : HMO is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Gastrointestinal Diseases.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
October 23, 2023
Lead Product(s) : HMO
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Citrulline
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Recipient : Texas Tech University
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of 4 Weeks of Citrulline and Glutathione Supplementation on Arterial Function
Details : L-Citrulline is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
December 17, 2020
Lead Product(s) : Citrulline
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Recipient : Texas Tech University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Loughborough University
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of L-arginine and L-citrulline Supplementation on Muscle Respiration
Details : This drug candidate is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 26, 2019
Lead Product(s) : Undisclosed
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Loughborough University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Oregon Health and Science University
Deal Size : Inapplicable
Deal Type : Inapplicable
The Combination Effect of Citicoline and Omega-3
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 23, 2018
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Oregon Health and Science University
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Cognitive Effects of Citicoline in Men and Women With Age-Associated Memory Impairment
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 12, 2017
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Biofortis Clinical Research, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : University of Cincinnati
Deal Size : Inapplicable
Deal Type : Inapplicable
Citicoline Effects on Cortical Membrane Structure and Function
Details : Citicoline is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 10, 2016
Lead Product(s) : Citicoline Sodium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : University of Cincinnati
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Istradefylline
Therapeutic Area : Neurology
Study Phase : Phase III
Recipient : Kyowa Kirin
Deal Size : Inapplicable
Deal Type : Inapplicable
Long Term Study of Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Details : Istradefylline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Parkinson Disease.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 20, 2015
Lead Product(s) : Istradefylline
Therapeutic Area : Neurology
Highest Development Status : Phase III
Recipient : Kyowa Kirin
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Istradefylline
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase I
Recipient : Kyowa Kirin
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Evaluate Abuse Potential of Istradefylline
Details : Istradefylline is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Substance-Related Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 20, 2015
Lead Product(s) : Istradefylline
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase I
Recipient : Kyowa Kirin
Deal Size : Inapplicable
Deal Type : Inapplicable

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Setria Glutathione
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : University of Florida
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Setria Glutathione is a Peptide drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Inapplicable
May 08, 2015
Lead Product(s) : Setria Glutathione
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : University of Florida
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All